327 related articles for article (PubMed ID: 36778126)
1. Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy.
Qiu C; Wu Y; Shi Q; Guo Q; Zhang J; Meng Y; Wang C; Xia F; Wang J; Xu C
Int J Biol Sci; 2023; 19(3):789-810. PubMed ID: 36778126
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
Li J; Wang Y; Zhu Y; Oupický D
J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticle‑mediated delivery of paclitaxel and nucleic acids for cancer therapy (Review).
Wang Z; Dong J; Zhao Q; Ying Y; Zhang L; Zou J; Zhao S; Wang J; Zhao Y; Jiang S
Mol Med Rep; 2020 Dec; 22(6):4475-4484. PubMed ID: 33173972
[TBL] [Abstract][Full Text] [Related]
5. Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery.
Song N; Zhang J; Zhai J; Hong J; Yuan C; Liang M
Acc Chem Res; 2021 Sep; 54(17):3313-3325. PubMed ID: 34415728
[TBL] [Abstract][Full Text] [Related]
6. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers for the simultaneous co-delivery of therapeutic genes and anticancer drugs.
Choudhury NN; He H
Curr Pharm Biotechnol; 2012 Jun; 13(7):1317-31. PubMed ID: 22201588
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of drugs and plasmid DNA for cancer therapy.
Teo PY; Cheng W; Hedrick JL; Yang YY
Adv Drug Deliv Rev; 2016 Mar; 98():41-63. PubMed ID: 26529199
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.
Zhang RX; Wong HL; Xue HY; Eoh JY; Wu XY
J Control Release; 2016 Oct; 240():489-503. PubMed ID: 27287891
[TBL] [Abstract][Full Text] [Related]
10. Application of vinyl polymer-based materials as nucleic acids carriers in cancer therapy.
Pereira PA; Serra MES; Serra AC; Coelho JFJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1820. PubMed ID: 35637638
[TBL] [Abstract][Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
12. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
Gandhi NS; Tekade RK; Chougule MB
J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
[TBL] [Abstract][Full Text] [Related]
13. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
Iyer AK; Duan Z; Amiji MM
Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
[TBL] [Abstract][Full Text] [Related]
14. Combinational application of metal-organic frameworks-based nanozyme and nucleic acid delivery in cancer therapy.
Ni D; Lin J; Zhang N; Li S; Xue Y; Wang Z; Liu Q; Liu K; Zhang H; Zhao Y; Chen C; Liu Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1773. PubMed ID: 35014211
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in nanotechnology for cancer therapy.
Tang MF; Lei L; Guo SR; Huang WL
Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
18. Novel multi-targeted nanoparticles for targeted co-delivery of nucleic acid and chemotherapeutic agents to breast cancer tissues.
Amani A; Alizadeh MR; Yaghoubi H; Nohtani M
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111494. PubMed ID: 33255061
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acid-based therapy for brain cancer: Challenges and strategies.
Zhang Z; Conniot J; Amorim J; Jin Y; Prasad R; Yan X; Fan K; Conde J
J Control Release; 2022 Oct; 350():80-92. PubMed ID: 35970297
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in co-delivery nanosystems for synergistic action in cancer treatment.
Carvalho BG; Vit FF; Carvalho HF; Han SW; de la Torre LG
J Mater Chem B; 2021 Feb; 9(5):1208-1237. PubMed ID: 33393582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
